1004081

Shire Human Genetic Therapies, Inc. — FEI 3009340644

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 20, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lexington, MA (United States)